Unknown

Dataset Information

0

Cost-effectiveness analysis of using the TBX6-associated congenital scoliosis risk score (TACScore) in genetic diagnosis of congenital scoliosis.


ABSTRACT: BACKGROUND:We previously reported a novel clinically distinguishable subtype of congenital scoliosis (CS), namely, TBX6-associated congenital scoliosis (TACS). We further developed the TBX6-associated CS risk score (TACScore), a multivariate phenotype-based model to predict TACS according to the patient's clinical manifestations. In this study, we aimed to evaluate whether using the TACScore as a screening method prior to performing whole-exome sequencing (WES) is more cost-effective than using WES as the first-line genetic test for CS. METHODS:We retrospectively collected the molecular data of 416 CS patients in the Deciphering disorders Involving Scoliosis and COmorbidities (DISCO) study. A decision tree was constructed to estimate the cost and the diagnostic time required for the two alternative strategies (TACScore versus WES). Bootstrapping simulations and sensitivity analyses were performed to examine the distributions and robustness of the estimates. The economic evaluation considered both the health care payer and the personal budget perspectives. RESULTS:From the health care payer perspective, the strategy of using the TACScore as the primary screening method resulted in an average cost of $1074.2 (95%CI: $1044.8 to $1103.5) and an average diagnostic duration of 38.7d (95%CI: 37.8d to 39.6d) to obtain a molecular diagnosis for each patient. In contrast, the corresponding values were $1169.6 (95%CI: $1166.9 to $1172.2) and 41.4d (95%CI: 41.1d to 41.7d) taking WES as the first-line test (P?

SUBMITTER: Chen Z 

PROVIDER: S-EPMC7493351 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cost-effectiveness analysis of using the TBX6-associated congenital scoliosis risk score (TACScore) in genetic diagnosis of congenital scoliosis.

Chen Zefu Z   Yan Zihui Z   Yu Chenxi C   Liu Jiaqi J   Zhang Yanbin Y   Zhao Sen S   Lin Jiachen J   Zhang Yuanqiang Y   Wang Lianlei L   Lin Mao M   Huang Yingzhao Y   Li Xiaoxin X   Niu Yuchen Y   Wang Shengru S   Wu Zhihong Z   Qiu Guixing G   Zhang Terry Jianguo TJ   Wu Nan N  

Orphanet journal of rare diseases 20200915 1


<h4>Background</h4>We previously reported a novel clinically distinguishable subtype of congenital scoliosis (CS), namely, TBX6-associated congenital scoliosis (TACS). We further developed the TBX6-associated CS risk score (TACScore), a multivariate phenotype-based model to predict TACS according to the patient's clinical manifestations. In this study, we aimed to evaluate whether using the TACScore as a screening method prior to performing whole-exome sequencing (WES) is more cost-effective tha  ...[more]

Similar Datasets

| S-EPMC6659397 | biostudies-literature
| S-EPMC4326244 | biostudies-literature
| S-EPMC7549550 | biostudies-literature
| S-EPMC3820596 | biostudies-literature
| S-EPMC5742745 | biostudies-literature
| S-EPMC1069035 | biostudies-literature
| S-EPMC4480874 | biostudies-literature
| S-EPMC4156513 | biostudies-other
| S-EPMC5518949 | biostudies-literature
| S-EPMC5784211 | biostudies-literature